ESC 365 - The effect of GLP-1RAs on cardiovascular disease and cardio-metabolic risk factors in patients with obesity and/or type 2 diabetes

Open Access

The effect of GLP-1RAs on cardiovascular disease and cardio-metabolic risk factors in patients with obesity and/or type 2 diabetes

Session: A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future

Topic: Obesity and Diabetes

Speaker: Professor S. Verma (Toronto, CA)

Sponsored by Novo Nordisk

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

31 presentations

3 followers

5 more presentations in this session

Welcome and introductions: cardiovascular risk in people with type 2 diabetes and/or obesity

Speaker: Professor N. Marx (Aachen, DE)

GLP-1RAs: what does the future hold?

Speaker: Doctor T. Vilsboll (Copenhagen, DK)

A focus on the practical: how can cardiologists best utilise GLP-1RAs in the clinic?

Speaker: Professor N. Marx (Aachen, DE)

Panel discussion and Q&A

Closing

Speaker: Professor N. Marx (Aachen, DE)

Access the full session

A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future

Speakers: Professor S. Verma, Professor N. Marx, Doctor T. Vilsboll, Professor N. Marx, Professor N. Marx

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources